Private finance: Amolyt Pharma, IASO Bio, Aiforia, Anjarium Biosciences, Intrance Medical Systems, Prospection

Australia: Prospection, which uses real world data to improve decision making and health outcomes, has raised A$45m (US$32.7m) in a Series B round of funding. The financing was led by a new investor, Ellerson JAADE, with existing shareholders, Main Sequence and Horizons Ventures, also joining the round. Prospection’s AI algorithms follow millions of de-identified patients…

You must be a HMI Subscriber to view this content.

Subscribe Now »